Galenica AG, founded in 1996 and headquartered in Switzerland, is a leading healthcare company dedicated to improving patient care through innovative pharmaceutical and medical solutions. The company specializes in the distribution of pharmaceuticals and the provision of healthcare services, making it an integral player in the Swiss healthcare market.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| GALESW 1.00% 2026-12-15 CHFGalenica AG | Switzerland | 2026-12-15 | 1.000 | 0.54 |
| GALESW 1.65% 2031-04-30 CHFGalenica AG | Switzerland | 2031-04-30 | 1.650 | 0.97 |
| GALESW 2.35% 2029-11-08 CHFGalenica AG | Switzerland | 2029-11-08 | 2.350 | 0.83 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Galenica AG began issuing bonds in 2017, reinforcing its financial stability and enabling further investment in its growth initiatives. Notable issuances include a ₣100 million bond in 2020, which was well-received and showcased strong demand in the healthcare sector. Currently, Galenica's bonds offer competitive yields compared to the industry average, reflecting investor confidence in its robust business model and strategic focus. Recent news indicates an increased interest in green bond offerings, aligning with Galenica's commitment to sustainability.